Table 1 Patient characteristics
All patients (n = 458) | |
|---|---|
Demographics | |
Age (years) – median [IQR] | 45 (32–62) |
Female gender – n (%) | 273 (59.6 %) |
Comorbidities | |
Presence of any comorbidity – n (%) | 70 (15.3 %) |
Finale diagnosis | |
Upper RTI | 184 (40.2 %) |
Acute rhinosinusitis – n (%) | 104 (22.7 %) |
Acute pharyngitis/tonsillitis – n (%) | 75 (16.4 %) |
Acute otitis media – n (%) | 5 (1.1 %) |
Lower non-pneumonic RTI | 205 (44.8 %) |
Common cold – n (%) | 31 (6.8 %) |
Acute bronchitis – n (%) | 140 (30.6 %) |
Influenza – n (%) | 4 (0.9 %) |
Exacerbated COPD – n (%) | 21 (4.6 %) |
Exacerbated asthma – n (%) | 9 (2 %) |
Lower pneumonic RTI | 69 (15.1 %) |
Medical outcome of patients | |
Days with restricted activities within 14 days – median [IQR] | 9 (6–12) |
Persisting discomfort after 14 days | 208 (45.7 %) |
Degree of discomfort (scale 1–10) – median [IQR] | 2 (1–5) |
Biomarkers | |
CRP mg/dL median (SD) [IQR] | 31 (60) (8.3-72.7) |
PCT μg/L median (SD) [IQR] | 0.08 (2.11) (0.05-0.11) |